Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.
Gonzàlez de Requena
Daniel
D
Pharmacology Unit, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
Núñez
Marina
M
de Mendoza
Carmen
C
Jiménez-Nàcher
Inmaculada
I
Soriano
Vincent
V
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D019888:Nelfinavir / Q000097:blood* / Q000627:therapeutic use; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D017211:Treatment Failure
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019888:Nelfinavir